טוען...
Allogeneic hematopoietic cell transplantation for consolidation of VGPR or CR for newly diagnosed multiple myeloma
Allogeneic hematopoietic cell transplantation (HCT) is a potentially curative approach in patients with multiple myeloma, but its use for consolidation of first remission has not yet been fully explored. Twenty-two myeloma patients with very good partial response (VGPR) or CR received allogeneic per...
שמור ב:
הוצא לאור ב: | Bone Marrow Transplant |
---|---|
Main Authors: | , , , , , , , , , |
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
2013
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4500071/ https://ncbi.nlm.nih.gov/pubmed/23542223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2013.37 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|